We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GIM
251
Gyrus Investment Management
Ontario, Canada
$1.52M +$1.51M +15,620 New
EWM
252
Evercore Wealth Management
New York
$1.51M +$1.58M +16,350 New
TMAM
253
Tokio Marine Asset Management
Japan
$1.5M +$1.57M +16,292 New
P
254
Pitcairn
Pennsylvania
$1.45M +$1.51M +15,686 New
N
255
Nuveen
North Carolina
$1.41M +$1.48M +15,332 New
CONA
256
Capital One National Association
New York
$1.41M +$1.48M +15,317 New
LMF
257
LMR Master Fund
Cayman Islands
$1.41M +$1.47M +15,283 New
Cambridge Investment Research Advisors
258
Cambridge Investment Research Advisors
Iowa
$1.39M +$1.45M +15,068 New
AAM
259
Aureus Asset Management
Massachusetts
$1.37M +$1.43M +14,890 New
MCM
260
Matterhorn Capital Management
Texas
$1.34M +$1.41M +14,585 New
IAM
261
Impax Asset Management
New Hampshire
$1.26M +$1.31M +13,639 New
NA
262
Navellier & Associates
Nevada
$1.25M +$1.3M +13,500 New
IGIM
263
I.G. Investment Management
Manitoba, Canada
$1.24M +$1.29M +13,410 New
WBC
264
Westpac Banking Corp
Australia
$1.24M +$1.29M +13,401 New
RIG
265
Roosevelt Investment Group
New York
$1.23M +$1.29M +13,359 New
William Blair & Company
266
William Blair & Company
Illinois
$1.22M +$1.27M +13,176 New
Schroder Investment Management Group
267
Schroder Investment Management Group
United Kingdom
$1.21M +$1.26M +13,097 New
Mirae Asset Global Investments
268
Mirae Asset Global Investments
South Korea
$1.15M +$1.2M +12,501 New
Canada Pension Plan Investment Board
269
Canada Pension Plan Investment Board
Ontario, Canada
$1.12M +$1.17M +12,100 New
CBOA
270
Commonwealth Bank of Australia
Australia
$1.08M +$1.13M +11,700 New
MAM
271
Martingale Asset Management
Massachusetts
$1.05M +$1.09M +11,356 New
RCM
272
Riverhead Capital Management
Delaware
$1.01M +$1.06M +11,000 New
SCM
273
Stux Capital Management
New York
$978K +$1.02M +10,600 New
LPL Financial
274
LPL Financial
California
$971K +$1.01M +10,530 New
MSU
275
Maple Securities USA
New Jersey
$944K +$987K +10,238 New
9 10
11
12 13

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.